Advisor: Edward Berger, PhD

Edward E. Berger, Ph.D.

Edward Berger has nearly 30 years experience in health services, medical technology and life sciences corporate communications, strategic planning, reimbursement and regulatory policy.

As a member of the senior management teams of Fresenius Medical Care, Thermo Cardiosystems and ABIOMED, Dr. Berger exercised responsibility for strategically sensitive communications with government agencies, news media and investors and served as principal corporate spokesperson through numerous crises and other high visibility events.

Through his consultancy, Larchmont Strategic Advisors, he helps life sciences companies create and implement integrated strategies to address the obstacles and opportunities they face in their efforts to secure public and private insurer coverage and optimal reimbursement for new or evolving technologies.

Focusing on issues that arise at the intersection of public policy, corporate strategy development, and internal and external advocacy, Dr. Berger helps clients to deal effectively with the strategic challenges posed by the rapidly evolving healthcare regulatory and policy environment.  His clients have included companies in fields such as mechanical circulatory support, cardiology, orthopedics, neural monitoring and neuromodulation, gastrointestinal surgery, pulmonary medicine, nuclear medicine, diagnostic imaging, clinical laboratory testing, and personalized medicine.

Dr. Berger is a member of Mass Medical Angels, a mentor in Boston University’s IGNITE program, and Past President of the Medical Development Group, a 400 member professional association of individuals professionally committed to the medical device and related life sciences business sectors.  He has a Bachelor’s Degree in Government from Harvard College, and earned his Ph.D. in Political Science at Boston University, where he was later Assistant Professor of Political Science and Chair of the Urban Affairs and Planning program.